EGFR and colorectal cancer: Furthermore, cetuximab and panitumumab, two anti-epidermal growth factor receptor (EGFR) monoclonal antibodies frequently used in the treatment of colorectal cancer, directly affect kidney convoluted tubules, leading to renal magnesium wasting (291, 295).